Last $123.15 USD
Change Today -0.52 / -0.42%
Volume 1.1M
VRTX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Frankfurt
As of 1:59 PM 01/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Terrence C. Kearney

Independent Director, Chairman of Audit & Finance Committee and Member of Management Development & Compensation Committee, Vertex Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 32 board members in 3 different organizations across 5 different industries.

See Board Relationships
59$808,422

Background*

Mr. Terrence C. Kearney, also known as Terry, served as the Chief Operating Officer of Hospira Inc., from April 25, 2006 to January 4, 2011 and also served as its Senior Vice President of Finance and Chief Financial Officer from April 30, 2004 to 2006. Mr. Kearney served on the Executive Management Team for Hospira, Inc., a specialty pharmaceutical and medication delivery company, from April 2004 to January 2011. Mr. Kearney had broad responsibility for the global operations, ...

Read Full Background

Corporate Headquarters*

50 Northern Avenue
Boston, Massachusetts 02210

United States

Phone: 617-341-6100
Fax: --

Board Members Memberships*

2011-Present
Independent Director, Chairman of Audit & Finance Committee and Member of Management Development & Compensation Committee
2014-Present
Director and Member of Compensation Committee
2014-Present
Director and Chairman of Audit Committee

Education*

BA
University of Illinois-Urbana-Champaign
Master's Degree
University of Denver
MBA
University of Denver

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options78,750
Unexercisable Options11,250
Total Number of Options90,000

Total Compensation*

Total Annual Cash Compensation$80,000
Total Calculated Compensation$808,422
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRTX:US $123.15 USD -0.52

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
Jean-Jacques Bienaime Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$868.8K
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
$876.9K
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERTEX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.